347873-67-0

Basic information

• Product Name: 4-(2-PHENOXYETHYL)PIPERIDINE
• Synonyms: 4-(2-PHENOXYETHYL)PIPERIDINE
• CAS NO: 347873-67-0
• Molecular Formula: C₁₃H₁₉NO
• Molecular Weight: 205.29606
• Mol File: 347873-67-0.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 312.0±15.0 °C(Predicted)
• Appearance: /
• Density: 0.984±0.06 g/cm3(Predicted)
• PKA: 10.58±0.10(Predicted)
• CAS DataBase Reference: 4-(2-PHENOXYETHYL)PIPERIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(2-PHENOXYETHYL)PIPERIDINE(347873-67-0)
• EPA Substance Registry System: 4-(2-PHENOXYETHYL)PIPERIDINE(347873-67-0)

Safety Data

• Hazardous Substances Data: 347873-67-0(Hazardous Substances Data)

Upstream product

• 622-26-4 4-(2-Hydroxyethyl)piperidine 
• 108-95-2 phenol 
• 252918-94-8 1-(tert-butoxycarbonyl)-4-[2-phenoxyethyl]piperidine 
• 89151-46-2 tert-butyl 4-(2-iodoethyl)piperidine-1-carboxylate 
• 89151-44-0 4-(2-hydroxyethyl)piperidine-1-carboxylic acid tert-butyl ester 

Downstream Products

• 252918-95-9 4-(2-phenoxyethyl)-piperidine hydrochloride salt 

Relevant articles and documents

NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS AND THE USES THEREOF

The invention relates to pyridinyl nicotinic acetylcholine receptor ligands, compositions comprising an effective amount of a pyridinyl nicotinic acetylcholine receptor ligand and methods to treat or prevent a condition, such as depression and nicotine dependence, comprising administering to an animal in need thereof an effective amount of a pyridinyl nicotinic acetylcholine receptor ligand.

PIPERIDINE AND PIPERAZINE DERIVATIVES

Compounds of general formula (Ia): in which R1, A1, m, X, n, Y and R3 have any of the meanings given in the specification, have affinity for sigma receptors and are useful in the treatment of disorders of the central nervous system.

PYRIDYL NON-AROMATIC NITROGENATED HETEROCYCLIC-1-CARBOXYLATE ESTER DERIVATIVE

[Problem] To provide a compound usable for treatment of diseases associated with fatty acid amide hydrolase (FAAH), especially for treatment of urinary frequency and urinary incontinence, overactive bladder and/or pain. [Means for Solution] We have found that a novel pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate derivative and its pharmaceutically acceptable salt has a potent FAAH-inhibitory activity. Further, the pyridyl non-aromatic nitrogen-containing heterocyclic-1-carboxylate derivative of the present invention has an excellent effect for increasing an effective bladder capacity, an excellent effect for relieving urinary frequency and an excellent anti-allodynia effect, and is therefore usable for treatment of urinary frequency and urinary incontinence, overactive bladder and/or pain.